GABABreceptors in the bladder and bowel: therapeutic potential for positive allosteric modulators?: Commentary on Kalinichevet al., Br J Pharmacol 171: 995-1006

The Concise Guide to PHARMACOLOGY 2013/14: Ligand-Gated Ion Channels

(2013) Stephen P.H. Alexander et al.   BRITISH JOURNAL OF PHARMACOLOGY

The Concise Guide to PHARMACOLOGY 2013/14: G Protein-Coupled Receptors

(2013) Stephen P.H. Alexander et al.   BRITISH JOURNAL OF PHARMACOLOGY

ADX71441, a novel, potent and selective positive allosteric modulator of the GABABreceptor, shows efficacy in rodent models of overactive bladder

(2013) M Kalinichev et al.   BRITISH JOURNAL OF PHARMACOLOGY

Overlap between functional GI disorders and other functional syndromes: what are the underlying mechanisms?

(2012) S. E. Kim et al.   NEUROGASTROENTEROLOGY AND MOTILITY

Do the urinary bladder and large bowel interact, in sickness or in health?: ICI-RS 2011

(2012) Anna P. Malykhina et al.   NEUROUROLOGY AND URODYNAMICS

A Gut Feeling about GABA: Focus on GABAB Receptors

(2010) Niall P. Hyland et al.   Frontiers in Pharmacology

Changes in afferent activity after spinal cord injury

(2009) William C. de Groat et al.   NEUROUROLOGY AND URODYNAMICS

The GABAB receptor agonist, baclofen, and the positive allosteric modulator, CGP7930, inhibit visceral pain-related responses to colorectal distension in rats

(2008) Mikael Brusberg et al.   NEUROPHARMACOLOGY